查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1929595

疝氣和腹壁手術產品市場（按產品類型、解剖結構、手術方式、材料類型、最終用途和配銷通路分類），全球預測，2026-2032年

Hernia & Abdominal Wall Surgery Products Market by Product Type, Anatomical Location, Procedure Type, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年疝氣和腹壁手術產品市場價值為8.1421億美元，預計到2026年將成長至8.7526億美元，年複合成長率為6.50%，到2032年將達到12.6593億美元。

關鍵市場統計數據
基準年 2025 8.1421億美元
預計年份：2026年 8.7526億美元
預測年份 2032 1,265,930,000 美元
複合年成長率 (%) 6.50%

本書以臨床觀點，介紹了不斷發展的醫療設備趨勢、手術偏好以及影響疝氣和腹壁治療的證據需求。

疝氣和腹壁手術始終處於臨床緊迫性和持續創新之間的交會點，其驅動力在於既要改善患者預後，又要最佳化手術全期效率。這些手術中使用的器械和耗材涵蓋了廣泛的技術頻譜，從植入式網片和生物移植物到先進的固定系統和微創器械。生物材料和手術平台的進步，以及外科醫師偏好的轉變，造就了因臨床適應症和醫療機構而異的多樣化應用模式。

本文簡要分析了正在重塑臨床實踐、器械研發和採購重點的技術、監管和供應鏈變革。

現代腹壁外科手術格局正受到多種因素的共同影響，這些因素正在重塑臨床實踐和商業策略。微創平台的技術進步，特別是機器人輔助系統的成熟，正在拓展外科醫生進行複雜修復和精準分離的能力，從而影響對相容網片、固定方法和器械的需求。同時，材料科學的進步也拓展了選擇範圍，從傳統的合成材料轉向複合和生物網膜網片旨在解決污染風險、生物反應和長期重塑等問題。

評估2025年美國對醫療設備採購、價格透明度和臨床准入徵收關稅對營運、採購和供應連續性的影響

2025年美國實施的政策和貿易變化為腹壁外科領域的跨國供應鏈和臨床採購慣例帶來了新的考量。關稅調整及相關貿易措施改變了零件和成品的採購策略，尤其對於那些依賴跨境製造網路生產聚合物、生物製程和精密儀器的公司而言更是如此。為此，製造商和經銷商正在評估替代籌資策略、區域製造地地點和庫存管理技術，以維持供應的連續性並控制成本風險。

詳細的細分分析，將採用趨勢與產品類型、解剖適應症、手術路徑、材料選擇、最終用戶和分銷管道聯繫起來。

這種細分為理解疝氣和腹壁手術生態系統中產品開發、臨床應用和分銷策略如何相互交織提供了一個實用的框架。以產品類型為基礎的市場結構包括：防沾黏產品（分為薄膜、凝膠和粉末製劑）；固定裝置（包括黏合劑、縫線和縫合釘）。網片產品系列分為生物網片、複合網片和合成網片。生物網片進一步細分為同種異體移植、自體移植和異質骨移植；複合網片分為重型和輕型；合成網片則依聚合物種類細分，包括聚酯、聚丙烯和聚四氟乙烯（PTFE）。手術器械包括牽開器、手術刀和套管針系統。這些產品特性影響臨床選擇標準，涵蓋了從操作特性和組織相容性到微創手術中的易用性等各個方面。

從跨區域觀點探討採納、監管差異、報銷影響和供應韌性如何影響全球主要醫療保健區域的臨床可近性

區域趨勢對腹壁外科產品的研發重點、監管策略和上市時間表有顯著影響。在美洲，領先的公立和私立醫療機構正積極推動微創和機器人技術的早期應用，而大規模綜合醫療系統則強調標準化通訊協定、醫療設備整合和療效評估，以加速臨床療效顯著的產品上市。相較之下，歐洲、中東和非洲（EMEA）的法規結構和報銷機制更為多樣化，區域核准流程、國家採購流程以及醫院間的合作能力共同決定了技術應用的速度和範圍。一些地區優先考慮長期安全性數據和成本效益評估，這會影響生物製藥和合成製劑的商業性化推廣路徑。

策略性公司分析和競爭考察揭示了產品系列的廣度、臨床證據和供應可靠性如何使腹壁手術生態系統中的公司脫穎而出。

疝氣和腹壁手術領域的競爭格局呈現出兩極化的特點：既有成熟的外科器械製造商，也有專注於生物製藥、固定系統和數位化手術整合等細分領域的靈活創新型專業公司。領導企業憑藉其全面的產品組合脫穎而出，這些產品組合將經臨床檢驗的植入與器械和教育服務相結合，從而降低手術操作的差異性。其策略性舉措通常著重於收購互補技術、與臨床研究網路合作以產生長期證據，以及投資於能夠增強手術全期支持和結果追蹤的數位化平台。

為製造商、醫療保健提供者、經銷商和支付方提供實際有效的建議，以加速安全應用、增強供應鏈韌性並最佳化價值。

價值鏈上的各相關人員可以採取實際行動，在確保臨床療效和營運穩定性的同時，加速創新技術的應用。製造商應優先產生反映真實世界實踐的有意義的臨床證據，投資於外科醫生教育和指導計畫以縮短學習曲線，並設計能夠適應不同手術方法和設施限制的產品。此外，他們還應透過對多家供應商進行資格認證、在條件允許的地區投資生產以及建立健全的品質和監管流程來提高供應鏈透明度，從而支持地域擴張。

該報告對支持其結論的混合定性和定量調查方法、相關人員參與和檢驗通訊協定進行了透明的描述。

本報告的分析採用了混合研究方法，結合了質性初步研究和定量檢驗工作。主要研究內容包括與各專科的執業外科醫生、醫院和門診手術中心的採購人員、醫療設備設計和監管專家以及製造和分銷機構的高級管理人員進行結構化訪談和諮詢會議。這些對話揭示了不同醫療機構在營運方面面臨的挑戰、臨床優先事項以及實施障礙。

簡潔的結論整合了策略要務、臨床重點和營運行動，旨在協調相關人員，推動疝氣和腹壁護理。

研究結果概述凸顯了一個充滿活力且機會豐富的領域，在這個領域中，材料創新、不斷發展的外科技術和商業策略相互交融，共同塑造著臨床實踐。關鍵建議強調了以下幾點的重要性：產品設計應與實際手術流程相契合；投資於能夠證明長期療效的臨床證據的生成；以及構建供應鏈韌性，以抵禦地緣政治和貿易相關的干擾。同樣重要的是，外科醫生、採購團隊和製造商之間需要進行多學科合作，以規範通訊協定，確保患者在不同臨床環境中獲得一致的就醫體驗。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的疝氣和腹壁手術產品市場

  • 抗黏附劑
    • 電影
    • 凝膠
    • 粉末
  • 固定裝置
    • 黏合劑
    • 縫合線
    • 釘
  • 網
    • 生物網膜
    • 複合網格
    • 合成網
  • 手術器械
    • 牽開器
    • 女性
    • 套管針系統

9. 按解剖部位分類的疝氣和腹壁手術產品市場

  • 大腿
    • 雙邊
    • 單方面
  • 食道裂孔疝
    • 食道旁疝
    • 滑翔型
  • 切口疝
    • 腹腔鏡
    • 開放性手術
  • 鼠蹊部
    • 直疝
    • 間接疝
    • 褲型疝
  • 臍疝氣
    • 合成的
    • 簡單的

10. 依手術方法分類的疝氣和腹壁手術產品市場

  • 腹腔鏡修補術
    • TAPP
    • TEP
  • 開放式維修
  • 機器人輔助維修
    • 多埠
    • 單站點

11. 按材料類型分類的疝氣和腹壁手術產品市場

  • 生物材料
    • 同種異體移植
    • 自體移植
    • 異質骨移植
  • 合成材料
    • 聚酯纖維
    • 聚丙烯
    • PTFE

12. 依最終用戶分類的疝氣和腹壁手術產品市場

  • 門診手術中心
  • 診所
  • 醫院

13. 疝氣和腹壁手術產品市場（依分銷管道分類）

  • 直銷
  • 批發商
  • 線上

14. 各地區疝氣及腹壁手術產品市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

15. 按組別分類的疝氣和腹壁手術產品市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國疝氣及腹壁手術產品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國疝氣和腹壁手術產品市場

第18章：中國疝氣與腹壁手術產品市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Atrium Medical Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Braun Surgical
  • Coloplast A/S
  • Conmed Corporation
  • Cook Medical LLC
  • Ethicon, Inc.
  • Integra LifeSciences Corporation
  • Leon Berard SAS
  • Medline Industries, LP
  • Medtronic plc
  • Molnlycke Health Care AB
  • Pfizer Inc.
  • Pfm Medical AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0A380695183E

The Hernia & Abdominal Wall Surgery Products Market was valued at USD 814.21 million in 2025 and is projected to grow to USD 875.26 million in 2026, with a CAGR of 6.50%, reaching USD 1,265.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 814.21 million
Estimated Year [2026] USD 875.26 million
Forecast Year [2032] USD 1,265.93 million
CAGR (%) 6.50%

An informed and clinically focused introduction to the evolving device landscape, procedural preferences, and evidence imperatives shaping hernia and abdominal wall care

Hernia and abdominal wall surgery remain at the intersection of clinical urgency and sustained innovation, driven by an imperative to improve patient outcomes while optimizing perioperative efficiency. Devices and consumables used in these procedures span a wide technical spectrum, from implantable meshes and biologic grafts to advanced fixation systems and minimally invasive instruments. Advances in biomaterials and procedural platforms have converged with evolving surgeon preferences, resulting in diverse adoption patterns that vary by clinical indication and healthcare setting.

Clinical pathways are increasingly guided by evidence that balances short-term recovery metrics with long-term functional outcomes. As a consequence, product developers are responding with solutions that emphasize ease of use in the operating room, predictable tissue integration, and lower complication profiles. Simultaneously, procurement leaders and hospital systems are prioritizing supply chain predictability and product standardization to reduce variability in patient care.

Moreover, digital tools and data-driven perioperative programs are reshaping how outcomes are tracked and how devices are evaluated in real-world settings. These dynamics create both opportunities and responsibilities for manufacturers, clinicians, and health systems as they align on value measures, training modalities, and post-market surveillance to ensure therapies deliver consistent clinical benefit across diverse patient populations.

A concise analysis of convergent technological, regulatory, and supply chain shifts that are reorienting clinical practice, device development, and procurement priorities

The contemporary landscape of abdominal wall surgery is being transformed by several convergent forces that are redefining clinical practice and commercial strategy. Technological progress in minimally invasive platforms-particularly the maturation of robotic-assisted systems-has expanded surgeon capabilities for complex repairs and refined dissection, thereby influencing demand for compatible meshes, fixation methods, and instrumentation. Concurrently, materials science advances have broadened options from traditional synthetic constructs to composite and biologic meshes designed to address contamination risk, host response, and long-term remodeling.

Beyond technology, regulatory pathways and clinical guidelines have evolved to place greater emphasis on patient safety and long-term outcomes, which in turn amplifies the importance of robust clinical evidence and post-market registries. Supply chain resilience and localization strategies have emerged as strategic priorities for manufacturers seeking to mitigate disruption and manage costs while maintaining quality and availability. Additionally, shifting reimbursement paradigms and hospital procurement models are encouraging bundled care approaches that integrate devices, perioperative protocols, and outcome monitoring.

Collectively, these shifts demand that stakeholders adopt a systems-level perspective: product development must align with surgical workflows and payer expectations; clinical education must support safe adoption; and manufacturers must invest in data generation and supply chain agility to stay competitive in a rapidly evolving environment.

Evaluating the operational, procurement, and supply continuity consequences of 2025 United States tariff measures on device sourcing, pricing transparency, and clinical access

Policy and trade changes enacted in the United States in 2025 have introduced a new set of considerations for multinational supply chains and clinical procurement practices in abdominal wall surgery. Tariff adjustments and related trade measures have altered the calculus for sourcing components and finished devices, particularly for firms that rely on cross-border manufacturing networks for polymers, biologic processing, and precision instruments. In response, manufacturers and distributors have been evaluating alternative sourcing strategies, regional manufacturing footprints, and inventory approaches to preserve continuity of supply and control cost exposure.

Clinicians and hospital procurement teams are encountering increased complexity in vendor negotiations and total cost assessments, prompting a renewed emphasis on predictable lead times and transparent costing. The response from suppliers has included efforts to enhance local inventory buffers, accelerate qualification of secondary suppliers, and re-examine pricing models to share risk across the value chain. For devices that incorporate specialized materials or proprietary biologic inputs, regulatory and quality validation timelines have become a critical component of any relocation or supplier diversification strategy.

While these measures add transactional complexity, they also create openings for manufacturers that can demonstrate supply chain reliability, proven clinical effectiveness, and streamlined regulatory compliance. Consequently, strategic investments in regional manufacturing capability, enhanced quality systems, and direct engagement with procurement stakeholders are proving to be valuable differentiators in an environment shaped by evolving trade policy.

In-depth segmentation analysis that connects product modalities, anatomical indications, procedural pathways, material choices, end users, and distribution channels to adoption dynamics

Segmentation provides a practical framework for understanding how product development, clinical adoption, and distribution strategies intersect across the hernia and abdominal wall surgery ecosystem. Based on product type, the landscape includes Adhesion Barrier products differentiated as film, gel, and powder formulations; Fixation Devices encompassing adhesives, sutures, and tacks; Mesh offerings segmented into Biologic Mesh, Composite Mesh, and Synthetic Mesh with further distinctions such as Allograft, Autograft, and Xenograft for biologics, Heavyweight and Lightweight variants for composite constructions, and polymer-specific choices like polyester, polypropylene, and PTFE for synthetics; and Surgical Instruments including retractors, scalpels, and trocar systems. These product distinctions shape clinical selection criteria, from handling characteristics and tissue compatibility to ease of deployment in minimally invasive settings.

Anatomical location segmentation highlights clinical heterogeneity with categories including femoral repairs (both bilateral and unilateral), hiatal variants (paraesophageal and sliding), incisional procedures (laparoscopic and open), inguinal types (direct, indirect, and pantaloon), and umbilical repairs classified as complex or simple. Procedure type segmentation further refines adoption dynamics, distinguishing laparoscopic repairs and their TAPP and TEP subapproaches, open repairs, and the growing cohort of robotic repairs that include multiport and single-site configurations. Material type delineation bifurcates offerings into biologic and synthetic routes, each with attendant subtypes and clinical trade-offs, while end-user segmentation captures the distinct procurement, workflow, and training needs of ambulatory surgical centers, clinics, and hospitals. Distribution channel segmentation contrasts direct sales, distributor relationships, and online channels that each influence pricing, service levels, and post-sale support.

Taken together, these segmentation lenses reveal that clinical choice is rarely driven by a single attribute. Instead, a combination of device characteristics, surgical approach, institutional capabilities, and supply chain considerations determines product adoption and long-term utilization patterns. Manufacturers that align product innovation with the nuanced requirements of specific anatomical indications, procedural approaches, and end-user settings will be better positioned to support clinical teams and capture durable adoption.

Cross-regional perspectives on adoption, regulatory variance, reimbursement influence, and supply resilience shaping clinical availability in major global healthcare regions

Regional dynamics exert a powerful influence on product development priorities, regulatory strategy, and adoption timelines in abdominal wall surgery. In the Americas, advanced private and public institutions often drive early adoption of minimally invasive and robotic techniques, while large integrated health systems emphasize standardized protocols, device consolidation, and outcome measurement that can accelerate adoption of products with strong clinical evidence. In contrast, regulatory frameworks and reimbursement mechanisms across Europe, Middle East & Africa present a more heterogeneous landscape where local approvals, national procurement processes, and varying hospital capabilities shape the pace and scope of uptake. Some jurisdictions prioritize long-term safety data and cost-effectiveness assessments, which influences the commercial pathway for biologic versus synthetic options.

Asia-Pacific exhibits a mix of rapid technology adoption in urban tertiary centers and pragmatic device selection in resource-constrained settings, encouraging manufacturers to offer a range of product tiers and service models. Across all regions, workforce training and surgeon experience remain central determinants of new technology integration, and investment in education and proctoring programs is often required to translate technical potential into routine practice. Finally, regional supply chain realities and trade policy influence stocking decisions and contract structures, prompting stakeholders to balance global product consistency with locally tailored logistical strategies that support uninterrupted clinical service delivery.

Strategic corporate and competitive insights revealing how portfolio breadth, clinical evidence, and supply reliability differentiate firms in the abdominal wall surgery ecosystem

Competitive landscapes in the hernia and abdominal wall sphere are characterized by a blend of established surgical device firms and agile specialty companies that focus on discrete segments such as biologics, fixation systems, or digital surgery integrations. Leaders differentiate through comprehensive portfolios that combine clinically validated implants with instrumentation and educational services that reduce procedural variability. Strategic activity often centers on acquiring complementary technologies, partnering with clinical research networks to generate long-term evidence, and investing in digital platforms that extend perioperative support and outcomes tracking.

Smaller, nimble players frequently compete by offering novel materials, single-purpose instruments, or targeted service models that appeal to specific end users or clinical subpopulations. These firms can leverage focused clinical trials, investigator-led registries, and targeted training initiatives to build credibility and drive regional adoption. At the same time, larger corporations pursue scale advantages in manufacturing, distribution reach, and reimbursement navigation, which can create barriers to entry but also foster collaborative opportunities through licensing or co-development agreements.

Across the competitive set, meaningful differentiation increasingly hinges on the ability to demonstrate clinical benefit, ensure supply chain reliability, and provide comprehensive training and post-market surveillance. Companies that invest in these capabilities position themselves to capture both clinical trust and procurement preference in an environment where institutions prioritize predictable outcomes and operational continuity.

Practical and high-impact recommendations for manufacturers, providers, distributors, and payers to accelerate safe adoption, strengthen supply resilience, and optimize value

Stakeholders across the value chain can adopt tangible actions to accelerate innovation adoption while safeguarding clinical outcomes and operational stability. Manufacturers should prioritize the generation of meaningful clinical evidence that reflects real-world practice, invest in surgeon education and proctoring programs to shorten learning curves, and design products that accommodate diverse surgical approaches and facility constraints. In addition, manufacturers must strengthen supply chain transparency by qualifying multiple suppliers, investing in regional manufacturing where feasible, and establishing robust quality and regulatory pathways to support geographic expansion.

Hospitals and ambulatory centers should incorporate standardized implant selection protocols, outcome tracking, and multidisciplinary decision-making frameworks to ensure consistent patient care and to inform procurement choices. Procurement leaders can leverage long-term service agreements and collaborative contracting to balance cost control with supply continuity, while also encouraging vendors to provide training and data support. Distributors and channel partners should evolve toward value-added service models that include inventory management, clinician training, and data integration services to remain relevant in a landscape that increasingly values bundled delivery of products and services.

Finally, policymakers and payers can support appropriate adoption by aligning reimbursement structures with evidence-based care pathways and by facilitating post-market data collection to monitor long-term safety and effectiveness. By coordinating across stakeholders and emphasizing transparent evidence and supply practices, the ecosystem can improve patient outcomes while fostering sustainable innovation.

Transparent description of the mixed qualitative and quantitative research approach, stakeholder engagements, and validation protocols that support the report's conclusions

The analysis underpinning this report was developed using a mixed-methods research approach that combined primary qualitative engagement with quantitative validation exercises. Primary inputs included structured interviews and advisory sessions with practicing surgeons across specialties, procurement leaders in hospitals and ambulatory surgical centers, device design and regulatory experts, and senior executives from manufacturing and distribution organizations. These interactions were used to surface operational challenges, clinical priorities, and adoption barriers in diverse care settings.

Secondary research supported contextual understanding and included a review of peer-reviewed clinical literature, regulatory filings, device labeling, clinical registry outputs, and supplier disclosures. Data synthesis employed thematic analysis to identify recurrent patterns and triangulation techniques to corroborate insights across multiple sources. Where relevant, scenario-based assessments were used to explore supply chain resilience, adoption pathways, and the implications of policy changes.

Validation steps included expert peer review by clinical and commercial advisors as well as iterative feedback cycles with industry stakeholders to ensure findings were practical, actionable, and reflective of current clinical practice. This layered methodology balances depth of qualitative understanding with rigorous cross-checking to produce robust, decision-ready conclusions.

A succinct conclusion synthesizing strategic imperatives, clinical priorities, and operational actions stakeholders must align on to advance hernia and abdominal wall care

The collective evidence points to a dynamic and opportunity-rich field in which material innovation, procedural evolution, and commercial strategy intersect to shape clinical practice. Key takeaways emphasize the importance of aligning product design with real-world surgical workflows, investing in clinical evidence generation that speaks to long-term outcomes, and building supply chain resilience to withstand geopolitical and trade-related disruptions. Equally important is the role of multidisciplinary collaboration among surgeons, procurement teams, and manufacturers to standardize protocols and to ensure consistent patient experiences across care settings.

Looking ahead, stakeholders that combine technical excellence with operational reliability and transparent outcomes measurement will be positioned to influence adoption curves and to demonstrate sustained clinical value. Incremental improvements in device handling, fixation reliability, and biologic integration-paired with effective clinician training and data-driven outcome monitoring-can collectively reduce variability in results and enhance patient recovery. In an environment where payer and institutional decision-making increasingly rewards demonstrable value, coordinated strategies that integrate clinical, commercial, and logistical considerations are essential for long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia & Abdominal Wall Surgery Products Market, by Product Type

  • 8.1. Adhesion Barrier
    • 8.1.1. Film
    • 8.1.2. Gel
    • 8.1.3. Powder
  • 8.2. Fixation Device
    • 8.2.1. Adhesives
    • 8.2.2. Sutures
    • 8.2.3. Tacks
  • 8.3. Mesh
    • 8.3.1. Biologic Mesh
    • 8.3.2. Composite Mesh
    • 8.3.3. Synthetic Mesh
  • 8.4. Surgical Instruments
    • 8.4.1. Retractors
    • 8.4.2. Scalpels
    • 8.4.3. Trocar System

9. Hernia & Abdominal Wall Surgery Products Market, by Anatomical Location

  • 9.1. Femoral
    • 9.1.1. Bilateral
    • 9.1.2. Unilateral
  • 9.2. Hiatal
    • 9.2.1. Paraesophageal
    • 9.2.2. Sliding
  • 9.3. Incisional
    • 9.3.1. Laparoscopic
    • 9.3.2. Open
  • 9.4. Inguinal
    • 9.4.1. Direct Hernia
    • 9.4.2. Indirect Hernia
    • 9.4.3. Pantaloon Hernia
  • 9.5. Umbilical
    • 9.5.1. Complex
    • 9.5.2. Simple

10. Hernia & Abdominal Wall Surgery Products Market, by Procedure Type

  • 10.1. Laparoscopic Repair
    • 10.1.1. TAPP
    • 10.1.2. TEP
  • 10.2. Open Repair
  • 10.3. Robotic Repair
    • 10.3.1. Multiport
    • 10.3.2. Single-Site

11. Hernia & Abdominal Wall Surgery Products Market, by Material Type

  • 11.1. Biologic
    • 11.1.1. Allograft
    • 11.1.2. Autograft
    • 11.1.3. Xenograft
  • 11.2. Synthetic
    • 11.2.1. Polyester
    • 11.2.2. Polypropylene
    • 11.2.3. PTFE

12. Hernia & Abdominal Wall Surgery Products Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Hernia & Abdominal Wall Surgery Products Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. Hernia & Abdominal Wall Surgery Products Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hernia & Abdominal Wall Surgery Products Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hernia & Abdominal Wall Surgery Products Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hernia & Abdominal Wall Surgery Products Market

18. China Hernia & Abdominal Wall Surgery Products Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Atrium Medical Corporation
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. Braun Surgical
  • 19.10. Coloplast A/S
  • 19.11. Conmed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Ethicon, Inc.
  • 19.14. Integra LifeSciences Corporation
  • 19.15. Leon Berard SAS
  • 19.16. Medline Industries, L.P.
  • 19.17. Medtronic plc
  • 19.18. Molnlycke Health Care AB
  • 19.19. Pfizer Inc.
  • 19.20. Pfm Medical AG
  • 19.21. Smith & Nephew plc
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. W. L. Gore & Associates, Inc.
  • 19.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (